Mazdutide
Shop MazdutideAlso called: Mazdutide UK & Lab UK
Mazdutide is a man-made copy of a natural gut hormone. It is being studied as a possible medicine. It is not approved for sale in the United States. Some companies sell it online as a 'research peptide,' but doctors cannot legally prescribe it for people.
In studies, this kind of medicine works on parts of the gut that talk to the brain. It can help people feel less hungry and feel full sooner. It may also help the body control blood sugar better. That is why scientists think it might help people with obesity or type 2 diabetes.
There is still a lot we do not know. Big human studies are still going on, so the full effects and side effects are not settled. The FDA says unapproved versions sold online have not been checked for safety, strength, or quality. They may be risky, and anyone with questions should talk to a real doctor.
Benefits
What Mazdutide Helps With
The benefits people report — backed by research.
Glycemic & metabolic (2)
Weight management (1)
Free: The Peptide Stack Cheat-Sheet
You just read the research on Mazdutide. The cheat-sheet maps the most-used peptide stacks — doses, timing, and what to check before buying — on one page.
No spam. Unsubscribe anytime.
Safety
Known Side Effects
Adverse effects reported in the research and by community use.
- Gastrointestinal adverse events (vomiting)Mild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ prnewswire.com
- Mild to moderate treatment-emergent adverse eventsMild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ prnewswire.com
Reported in research and community sources — not exhaustive. Discontinue use and consult a healthcare professional if side effects occur.
Get Mazdutide
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
News
Latest on Mazdutide
Dated, sourced reporting that mentions Mazdutide.
NuScience Peptides LLC
The FDA issued a warning letter to NuScience Peptides LLC for marketing unapproved injectable peptide drugs, including GLP-1/GLP-2/GLP-3 products and other peptides, on its website. The agency determined these products are unapproved new drugs under the FD&C Act. FDA warned that failure to correct the violations could lead to seizure or injunction.
Mazdutide approved in China as the first dual GCG/GLP-1 receptor agonist for chronic weight management
China's regulator has cleared mazdutide, the world's first dual glucagon/GLP-1 receptor agonist cleared anywhere for weight loss, for adults with overweight or obesity on top of diet and exercise. In the pivotal GLORY-1 trial the 6 mg dose produced 14.8% mean weight loss at 48 weeks, with half of participants losing at least 15% of body weight and liver fat falling by around 80%. The approval opens a new drug class beyond semaglutide and tirzepatide for the world's largest obesity market.
Wondering how Mazdutide pricing compares across suppliers? Our original market data shows the full picture.
See the State of the Peptide Market 2026 →